First Time Loading...

Illumina Inc
NASDAQ:ILMN

Watchlist Manager
Illumina Inc Logo
Illumina Inc
NASDAQ:ILMN
Watchlist
Price: 111.07 USD -2.96% Market Closed
Updated: May 18, 2024

Intrinsic Value

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. [ Read More ]

The intrinsic value of one ILMN stock under the Base Case scenario is 111.88 USD. Compared to the current market price of 111.07 USD, Illumina Inc is Undervalued by 1%.

Key Points:
ILMN Intrinsic Value
Base Case
111.88 USD
Undervaluation 1%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Illumina Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling ILMN stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Illumina Inc

Provide an overview of the primary business activities
of Illumina Inc.

What unique competitive advantages
does Illumina Inc hold over its rivals?

What risks and challenges
does Illumina Inc face in the near future?

Has there been any significant insider trading activity
in Illumina Inc recently?

Summarize the latest earnings call
of Illumina Inc.

What significant events have occurred
in Illumina Inc over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Illumina Inc.

Provide P/S
for Illumina Inc.

Provide P/E
for Illumina Inc.

Provide P/OCF
for Illumina Inc.

Provide P/FCFE
for Illumina Inc.

Provide P/B
for Illumina Inc.

Provide EV/S
for Illumina Inc.

Provide EV/GP
for Illumina Inc.

Provide EV/EBITDA
for Illumina Inc.

Provide EV/EBIT
for Illumina Inc.

Provide EV/OCF
for Illumina Inc.

Provide EV/FCFF
for Illumina Inc.

Provide EV/IC
for Illumina Inc.

Show me price targets
for Illumina Inc made by professional analysts.

What are the Revenue projections
for Illumina Inc?

How accurate were the past Revenue estimates
for Illumina Inc?

What are the Net Income projections
for Illumina Inc?

How accurate were the past Net Income estimates
for Illumina Inc?

What are the EPS projections
for Illumina Inc?

How accurate were the past EPS estimates
for Illumina Inc?

What are the EBIT projections
for Illumina Inc?

How accurate were the past EBIT estimates
for Illumina Inc?

Compare the revenue forecasts
for Illumina Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Illumina Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Illumina Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Illumina Inc compared to its peers.

Compare the P/E ratios
of Illumina Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Illumina Inc with its peers.

Analyze the financial leverage
of Illumina Inc compared to its main competitors.

Show all profitability ratios
for Illumina Inc.

Provide ROE
for Illumina Inc.

Provide ROA
for Illumina Inc.

Provide ROIC
for Illumina Inc.

Provide ROCE
for Illumina Inc.

Provide Gross Margin
for Illumina Inc.

Provide Operating Margin
for Illumina Inc.

Provide Net Margin
for Illumina Inc.

Provide FCF Margin
for Illumina Inc.

Show all solvency ratios
for Illumina Inc.

Provide D/E Ratio
for Illumina Inc.

Provide D/A Ratio
for Illumina Inc.

Provide Interest Coverage Ratio
for Illumina Inc.

Provide Altman Z-Score Ratio
for Illumina Inc.

Provide Quick Ratio
for Illumina Inc.

Provide Current Ratio
for Illumina Inc.

Provide Cash Ratio
for Illumina Inc.

What is the historical Revenue growth
over the last 5 years for Illumina Inc?

What is the historical Net Income growth
over the last 5 years for Illumina Inc?

What is the current Free Cash Flow
of Illumina Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Illumina Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Illumina Inc

Current Assets 2.6B
Cash & Short-Term Investments 1.1B
Receivables 635m
Other Current Assets 840m
Non-Current Assets 7.5B
PP&E 1.5B
Intangibles 5.5B
Other Non-Current Assets 458m
Current Liabilities 1.5B
Accounts Payable 201m
Accrued Liabilities 1.3B
Non-Current Liabilities 2.8B
Long-Term Debt 1.5B
Other Non-Current Liabilities 1.3B
Efficiency

Earnings Waterfall
Illumina Inc

Revenue
4.5B USD
Cost of Revenue
-1.7B USD
Gross Profit
2.8B USD
Operating Expenses
-3.9B USD
Operating Income
-1.1B USD
Other Expenses
-172m USD
Net Income
-1.3B USD

Free Cash Flow Analysis
Illumina Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

ILMN Profitability Score
Profitability Due Diligence

Illumina Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
35/100
Profitability
Score

Illumina Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

ILMN Solvency Score
Solvency Due Diligence

Illumina Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
High Altman Z-Score
Short-Term Solvency
51/100
Solvency
Score

Illumina Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ILMN Price Targets Summary
Illumina Inc

Wall Street analysts forecast ILMN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ILMN is 153.97 USD with a low forecast of 101 USD and a high forecast of 265.65 USD.

Lowest
Price Target
101 USD
9% Downside
Average
Price Target
153.97 USD
39% Upside
Highest
Price Target
265.65 USD
139% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Competitors Analysis
Illumina Inc

Ownership

ILMN Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

ILMN Price
Illumina Inc

1M 1M
-5%
6M 6M
+14%
1Y 1Y
-45%
3Y 3Y
-71%
5Y 5Y
-63%
10Y 10Y
-27%
Annual Price Range
111.07
52w Low
92.79
52w High
212.65
Price Metrics
Average Annual Return -5.61%
Standard Deviation of Annual Returns 28%
Max Drawdown -82%
Shares Statistics
Market Capitalization 17.7B USD
Shares Outstanding 159 300 000
Percentage of Shares Shorted 3.38%

ILMN Return Decomposition
Main factors of price return

What is price return decomposition?

ILMN News

Other Videos

Last Important Events
Illumina Inc

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Illumina Inc

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Illumina Inc Logo
Illumina Inc

Country

United States of America

Industry

Life Sciences Tools & Services

Market Cap

17.7B USD

Dividend Yield

0%

Description

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company is headquartered in San Diego, California and currently employs 9,800 full-time employees. The company went IPO on 2000-06-28. The firm operates through two segments: Core Illumina and GRAIL. Core Illumina products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. GRAIL is a healthcare company focused on early detection of multiple cancers. Its portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed for genetic analysis. Customers use its platforms to perform whole genome, de novo, exome and ribonucleic acid (RNA) sequencing, and targeted resequencing of specific gene regions and genes. The firm's BeadArray technology produces arrays that can perform many assays simultaneously. Customers use its array-based genotyping consumables for a range of analyses, including diverse species, disease-related mutations, and genetic characteristics associated with cancer.

Contact

CALIFORNIA
San Diego
5200 Illumina Way
+18582024500.0
https://www.illumina.com

IPO

2000-06-28

Employees

9 800

Officers

CEO & Director
Mr. Jacob Thaysen Ph.D.
Chief Information Officer
Ms. Carissa L. Rollins
Senior VP & General Counsel
Mr. Charles E. Dadswell Esq.
Executive Officer
Dr. Joydeep Goswami M.B.A., Ph.D.
President
Stephanie Campos
Chief Financial Officer
Mr. Ankur Dhingra
Show More
Chief of Global Operations
Mr. Kevin Carl Pegels
VP & Chief Accounting Officer
Mr. Scott Ericksen
Chief Technology Officer
Dr. Steven Barnard Ph.D.
Vice President of Investor Relations
Ms. Sallilyn Schwartz
Show Less

See Also

Discover More
What is the Intrinsic Value of one ILMN stock?

The intrinsic value of one ILMN stock under the Base Case scenario is 111.88 USD.

Is ILMN stock undervalued or overvalued?

Compared to the current market price of 111.07 USD, Illumina Inc is Undervalued by 1%.